Professor of Internal Medicine and Director, Division of Human Genetics; Joint Appointment, Cardiovascular Medicine, Heart Failure/Heart Transplant
Cardiology
Dr. Ray E. Hershberger, MD
|
|
Give Review
Hershberger is an expert in the field of Cardiology. He went to University of Nebraska College of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification", "Whos Who in Medicine and Healthcare" and "Fellow (FACC)". Hershberger is a published doctor and has 49 publications published. The lastest was: 'The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy.' Dr. Ray E. Hershberger accepts Medicare payments and is registered with Medicare.gov.
Publications
- The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy.
- Design and Implementation of a Randomized Controlled Trial of Genomic Counseling for Patients with Chronic Disease.
- Dilated Cardiomyopathy: the complexity of a diverse genetic architecture.
- Genetic evaluation of dilated Cardiomyopathy.
- Genetic testing in cardiovascular medicine: current landscape and future horizons.
- Return of genetic results in the familial dilated Cardiomyopathy research project.
- Temporal Relationship of Conduction System Disease and Ventricular Dysfunction in LMNA Cardiomyopathy.
- Exome Sequencing and Genome-Wide Linkage Analysis in 17 Families Illustrate the Complex Contribution of TTN Truncating Variants to Dilated Cardiomyopathy.
- Next-generation sequencing to identify genetic causes of cardiomyopathies.
- Assessment of LMNA Copy Number Variation in 58 Probands with Dilated Cardiomyopathy.
- Functional characterization of TNNC1 rare variants identified in dilated Cardiomyopathy.
- Dual Percutaneous Mechanical Circulatory Support as a Bridge to Recovery in Fulminant Myocarditis.
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies This document was developed as a partnership between t...
- Update 2011: clinical and genetic issues in familial dilated Cardiomyopathy.
- Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated Cardiomyopathy.
- Rare variant mutations identified in pediatric patients with dilated Cardiomyopathy.
- SCN5A rare variants in familial dilated Cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del.
- Clinical and genetic issues in dilated Cardiomyopathy: a review for genetics professionals.
- Late onset sporadic dilated Cardiomyopathy caused by a cardiac troponin T mutation.
- Research priorities in hypertrophic Cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.
- Identification of novel mutations in RBM20 in patients with dilated Cardiomyopathy.
- Rare variant mutations in pregnancy-associated or peripartum Cardiomyopathy.
- A glimpse into multigene rare variant genetics: triple mutations in hypertrophic Cardiomyopathy.
- Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated Cardiomyopathy.
- Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated Cardiomyopathy.
- Clinical and functional characterization of TNNT2 mutations identified in patients with dilated Cardiomyopathy.
- Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/Cardiomyopathy.
- Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated Cardiomyopathy.
- Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated Cardiomyopathy.
- Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.
- Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated Cardiomyopathy.
- Genetic testing and genetic counseling in cardiovascular genetic medicine: overview and preliminary recommendations.
- Family history: an essential tool for cardiovascular genetic medicine.
- The family history as a tool to identify patients at risk for dilated Cardiomyopathy.
- The use of positive inotropes in end-of-life Heart failure care.
- Mutations of presenilin genes in dilated Cardiomyopathy and heart failure.
- Clinical characteristics of 304 kindreds evaluated for familial dilated Cardiomyopathy.
- Beta-blocker use in decompensated Heart failure.
- Becker's muscular dystrophy and orthotopic Heart transplantation: perioperative considerations.
- Daclizumab to prevent rejection after cardiac transplantation.
- Prospective evaluation of an outpatient heart failure Disease management program designed for primary care: the Oregon model.
- Clinical and genetic issues in familial dilated Cardiomyopathy.
- Consensus statement: Palliative and supportive care in advanced Heart failure.
- Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage Heart failure.
- A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system Disease, and need for permanent pacemaker implantation.
- Pre-operative renal function predicts development of Chronic renal insufficiency after orthotopic heart transplantation.
- Periodic rescreening is indicated for family members at risk of developing familial dilated Cardiomyopathy.
- Cardiac troponin T lysine 210 deletion in a family with dilated Cardiomyopathy.
Schools
University of Nebraska College of Medicine
University Kans School Med
Washington Hospital Center
University Utah Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Whos Who in Medicine and Healthcare
- Fellow (FACC)
Education
-
University of Utah -
University of Kansas at Wichita -
Georgetown University Hospital - Washington Hospital Center -
University of Nebraska College of Medicine
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1548275050 | |
| NPPES Provider LastName | HERSHBERGER | |
| NPPES Provider FirstName | RAY | |
| NPPES Provider ZIPCode | 432101240 | |
| NPPES Provider State | OH | |
| Specialty Description | Cardiology | |
| Total Claim Count | 118.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548275050 |
| Last Name Of The Provider | HERSHBERGER |
| First Name Of The Provider | RAY |
| View All |
Similar Doctors
|
Dr. Mahmoud Houmsse, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Ralph S. Augostini, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vincent J. Pompili, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brent C. Lampert, DO |
|
|
Dr. Robert J. Eastway, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sreedhar R. Billakanty, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David A. Orsinelli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory B. Comfort Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter B. George, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica A. Ross, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mitesh N. Patel, DO |